** Shares of CogState Ltd CGS.AX jump as much as 11.9% to
A$2.45, their biggest intraday pct gain since Sept. 15
** The neuroscience technology firm says Q1 revenue almost
doubled from a year earlier to A$12.3 mln ($9.18 mln)
urn:newsml:reuters.com:*:nASXbjRZGh
** Adds Q1 revenue from clinical trials rose 93% to A$11.1
mln
** Stock notches its highest since Oct. 18
** CGS stock has nearly doubled in value this year as of
last close
($1 = 1.3398 Australian dollars)
(Reporting by Harish Sridharan in Bengaluru)
((harish.sridharan@thomsonreuters.com))